ACMG Public Policy Activities
ACMG is a strong advocate for its members—the professionals who comprise the genetic and genomic healthcare communities. By advocating for issues of highest priority to sustain our field and promote the ACMG’s core values and mission, we also improve the lives and health of the families with and at risk for heritable disorders, whom we serve.
joins Clinical and Laboratory Practice, and Education, as one of the three pillars in ACMG’s 2015 Strategic Plan, which charges us to “work with policymakers and payers to support the responsible application of genomics in medical practice”.
Listed below are national policy issues in which ACMG has been active. Under each issue are the policy documents ACMG has developed and/or to which it has responded. These include providing written public comments to proposed federal legislation, agency guidance and proposed rules; giving testimony before Congress; as well as lending technical assistance in crafting legislative and regulatory documents.